{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicchcyjprl3t427jv37divcmh6yglyrfhq2wuowocnfsgzzywrvje",
    "uri": "at://did:plc:5v5xdyhb3zf74bcdmcnazkrk/app.bsky.feed.post/3mltlnltv7vn2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibf2eifbc2h6cwvgzefvwpijvkrcwuzmwjqmpdtv4rdk2espz7lhe"
    },
    "mimeType": "image/jpeg",
    "size": 102526
  },
  "path": "/science/news-science/a-new-alzheimers-drug-reversed-memory-decline-in-mice-even-after-symptoms-appeared/",
  "publishedAt": "2026-05-14T17:52:47.000Z",
  "site": "https://www.zmescience.com",
  "tags": [
    "Mind & Brain",
    "News",
    "Alzheimer’s disease",
    "amyloid beta",
    "animal models",
    "brain research",
    "dementia",
    "epigenetics",
    "FLAV-27",
    "G9a",
    "memory loss",
    "Molecular Therapy",
    "mouse study",
    "neurodegenerative disease",
    "neuroscience",
    "tau protein"
  ],
  "textContent": "A new experimental Alzheimer’s compound called FLAV-27 improved memory and reduced disease-like damage in worms and mice.",
  "title": "A New Alzheimer’s Drug Reversed Memory Decline in Mice Even After Symptoms Appeared"
}